RADD PHARMACEUTICALS
Dead / Cancelled — Second extension request filed (statement of use) (as of 24 Apr 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97337739
- Mark type
- Stylized text
- Filed
- 30 Mar 2022
- Published for opposition
- 28 Feb 2023
- Attorney of record
- David Ewen
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research in the field of oncology and cancer treatment; Pharmaceutical research and development; Research and development in the field of oncology and cancer treatment
Owner
- RADD Pharmaceuticals, Inc., Westport, CT, US
- RADD Pharmaceuticals, Inc., Westport, CT, US
Prosecution history
- 25 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Apr 2024 — SOU EXTENSION 2 GRANTED
- 24 Apr 2024 — SOU EXTENSION 2 FILED
- 24 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 20 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Oct 2023 — SOU EXTENSION 1 GRANTED
- 18 Oct 2023 — SOU EXTENSION 1 FILED
- 18 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 25 Apr 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Feb 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Feb 2023 — PUBLISHED FOR OPPOSITION
- 08 Feb 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jan 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Jan 2023 — EXAMINER'S AMENDMENT ENTERED
- 19 Jan 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED